13F HOLDINGS REPORT (Amended)
Casdin Capital, LLC
Quarter ended Q3 2024 · Filed October 18, 2024 · Accession 0000919574-24-005948
Total Value
$1.31B
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOLIFE SOLUTIONS INC | BLFS | 8,707,165 | $186.6M | 14.25% |
| 2 | REVOLUTION MEDICINES INC | RVMDW | 4,406,875 | $171.0M | 13.06% |
| 3 | SAREPTA THERAPEUTICS INC | SRPT | 1,073,500 | $169.6M | 12.95% |
| 4 | STANDARD BIOTOOLS INC | LAB | 63,959,677 | $113.2M | 8.64% |
| 5 | GENEDX HOLDINGS CORP | WGSWW | 3,526,411 | $92.2M | 7.04% |
| 6 | AVIDITY BIOSCIENCES INC | 05370A108 | 2,084,841 | $85.2M | 6.50% |
| 7 | RELAY THERAPEUTICS INC | RLAY | 8,448,574 | $55.1M | 4.21% |
| 8 | ILLUMINA INC | ILMN | 480,000 | $50.1M | 3.83% |
| 9 | INTELLIA THERAPEUTICS INC | NTLA | 2,000,000 | $44.8M | 3.42% |
| 10 | ALNYLAM PHARMACEUTICALS INC | ALNY | 170,000 | $41.3M | 3.15% |
| 11 | BLUEPRINT MEDICINES CORP | 09627Y109 | 326,378 | $35.2M | 2.69% |
| 12 | DENALI THERAPEUTICS INC | DNLI | 1,300,000 | $30.2M | 2.30% |
| 13 | STRUCTURE THERAPEUTICS INC | GPCR | 700,000 | $27.5M | 2.10% |
| 14 | EXACT SCIENCES CORP | 30063P105 | 650,000 | $27.5M | 2.10% |
| 15 | TENAYA THERAPEUTICS INC | TNYA | 6,732,971 | $20.9M | 1.59% |
| 16 | NEUROGENE INC | NGNE | 524,616 | $19.1M | 1.46% |
| 17 | VERACYTE INC | VCYT | 857,904 | $18.6M | 1.42% |
| 18 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 800,000 | $16.8M | 1.28% |
| 19 | BEAM THERAPEUTICS INC | BEAM | 675,000 | $15.8M | 1.21% |
| 20 | VERVE THERAPEUTICS INC | 92539P101 | 3,059,094 | $14.9M | 1.14% |
| 21 | CENTURY THERAPEUTICS INC | IPSC | 5,190,506 | $13.2M | 1.01% |
| 22 | PLIANT THERAPEUTICS INC | PLRX | 1,000,000 | $10.8M | 0.82% |
| 23 | TANGO THERAPEUTICS INC | TNGX | 1,188,349 | $10.2M | 0.78% |
| 24 | 2SEVENTY BIO INC | 901384107 | 2,000,000 | $7.7M | 0.59% |
| 25 | CODEXIS INC | CDXS | 2,000,000 | $6.2M | 0.47% |
| 26 | CONTINEUM THERAPEUTICS INC | CTNM | 296,666 | $5.2M | 0.40% |
| 27 | KYVERNA THERAPEUTICS INC | KYTX | 575,000 | $4.3M | 0.33% |
| 28 | SYNDAX PHARMACEUTICALS INC | SNDX | 150,000 | $3.1M | 0.24% |
| 29 | ABSCI CORPORATION | ABSI | 973,260 | $3.0M | 0.23% |
| 30 | GUARDANT HEALTH INC | GH | 100,000 | $2.9M | 0.22% |
| 31 | PRIME MEDICINE INC | PRME | 367,175 | $1.9M | 0.14% |
| 32 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 1,035,859 | $1.4M | 0.11% |
| 33 | GRAIL INC | GRAL | 79,999 | $1.2M | 0.09% |
| 34 | EXSCIENTIA PLC | 30223G102 | 213,900 | $1.1M | 0.08% |
| 35 | MONTE ROSA THERAPEUTICS INC | GLUE | 261,014 | $976,192 | 0.07% |
| 36 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 1,459,747 | $487,993 | 0.04% |
| 37 | SINGULAR GENOMICS SYSTEMS IN | 82933R308 | 44,129 | $372,890 | 0.03% |
| 38 | KRONOS BIO INC | 50107A104 | 123,839 | $153,560 | 0.01% |